Panagora Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-49,438
Closed -$1.54M 1202
2025
Q1
$1.54M Sell
49,438
-14,226
-22% -$451K 0.01% 578
2024
Q4
$1.62M Buy
63,664
+544
+0.9% +$14.4K 0.01% 560
2024
Q3
$1.79M Hold
63,120
0.01% 556
2024
Q2
$1.66M Sell
63,120
-129,378
-67% -$3.59M 0.01% 569
2024
Q1
$5.85M Sell
192,498
-88,517
-31% -$2.61M 0.03% 309
2023
Q4
$7.89M Buy
281,015
+215,142
+327% +$5.91M 0.04% 255
2023
Q3
$1.79M Buy
65,873
+16,525
+33% +$491K 0.01% 561
2023
Q2
$1.52M Hold
49,348
0.01% 645
2023
Q1
$1.78M Buy
49,348
+17,778
+56% +$659K 0.01% 616
2022
Q4
$1.25M Sell
31,570
-19,088
-38% -$797K 0.01% 801
2022
Q3
$2.04M Sell
50,658
-66,325
-57% -$2.83M 0.01% 593
2022
Q2
$4.92M Buy
116,983
+105,620
+930% +$4.33M 0.03% 385
2022
Q1
$443K Hold
11,363
﹤0.01% 1251
2021
Q4
$453K Hold
11,363
﹤0.01% 1255
2021
Q3
$411K Sell
11,363
-2,498
-18% -$97.1K ﹤0.01% 1390
2021
Q2
$568K Sell
13,861
-1,647
-11% -$70.1K ﹤0.01% 1277
2021
Q1
$676K Buy
15,508
+8,349
+117% +$396K ﹤0.01% 1187
2020
Q4
$358K Buy
+7,159
New +$304K ﹤0.01% 1354

Other funds holding RPRX